Skip to main navigation
Skip to search
Skip to main content
MD Anderson Cancer Center Home
Help & FAQ
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Search by expertise, name or affiliation
Using multiple targeted therapies in oncology: Considerations for use, and progress to date in breast cancer
Catherine M. Kelly,
Aman U. Buzdar
Breast Medical Oncology
Research output
:
Contribution to journal
›
Article
›
peer-review
12
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Using multiple targeted therapies in oncology: Considerations for use, and progress to date in breast cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Breast Neoplasms
100%
Epidermal Growth Factor
68%
Letrozole
48%
Poly(ADP-ribose) Polymerase Inhibitors
46%
Clinical Trials
45%
Aromatase Inhibitors
43%
Triple Negative Breast Neoplasms
42%
Estrogen Receptors
32%
Progression-Free Survival
31%
Cyclin-Dependent Kinase 6
26%
Therapeutics
25%
Synthetic Lethal Mutations
25%
Cyclin-Dependent Kinase 4
24%
Fulvestrant
23%
Drug Approval
22%
Pharmaceutical Preparations
21%
Drug Therapy
20%
TOR Serine-Threonine Kinases
19%
Tamoxifen
18%
Progesterone Receptors
18%
United States Food and Drug Administration
17%
Congresses
17%
Drug Delivery Systems
17%
Routine Diagnostic Tests
16%
Drug Resistance
15%
Signal Transduction
13%
Technology
11%
Biomarkers
11%
Safety
10%